Tag Archives: NHIA to cover children with sickle cell

The National Health Insurance Authority (NHIA) will from July this year rollout free treatment for children with sickle cell and cancer registered with the scheme.   NHIA has adopted Hydroxyurea, a drug commonly used medicine for patients with SCD in developed countries approved by Ghana’s Food and Drugs Authority in …

Read More »